• SPECIALTY
  • PROVIDER INFO
  • EDUCATION
  • AFFILIATIONS
  • RESEARCH & PUBLICATIONS
  • ACHIEVEMENTS
  • PATIENT RATINGS & COMMENTS

Office locations

Los Angeles
Los Angeles
Samuel Oschin Cancer Center
3104232217
127 S San Vicente Blvd - 7th Floor
Los Angeles
CA
90048
Pancreatic Cancer Screening and Early Detection Program
3104236082
8730 Alden Drive, Second Floor East, Suite 204
Los Angeles
CA
90048

Specialty

  • IM/Hematology/Oncology

    Provider Info

    GENDER

    Male

    LANGUAGES

    Spanish, English

    EXPERIENCE

    18 years

    Education

    • University of Southern California
      Fellowship - Completed 2010
    • Los Angeles County + USC Medical Center
      Residency - Completed 2007
    • Los Angeles County + USC Medical Center
      Internship - Completed 2006
    • Tulane University School of Medicine
      Medical School - Completed 2003

    Research

    The current research focus of Andrew Hendifar, MD, is on developing new therapies for pancreatic cancer and neuroendocrine tumors. Dr. Hendifar has helped form multidisciplinary teams that specialize in the treatments of pancreatic cancer, and carcinoid and neuroendocrine tumors. Dr. Hendifar is the primary investigator for several groundbreaking therapies, including radioimmunotherapy for neuroendocrine tumors, anti-inflammatory therapy for pancreatic cancer and novel approaches to cancer cachexia. His national roles include SWOG GI Committee Member and a member of NIH Neuroendocrine Tumor Task Force. He also serves on the steering committee member for the Precision Promise Consortium and chairs the associated Supportive Care Committee. At Cedars Sinai he leads the Gastrointestinal Disease Research Group and is the founding Director of the Hematology and Oncology Fellowship Program.

    PUBLICATIONS

    • Khanuja J, Gresham G, Osipov A, Tuli R, Hendifar A. Treatment and underlying mechanisms of pancreatic cancer cachexia (PANCAX study). J Clin Oncol. 2015;33.
    • Hendifar A, Osipov A, Khanuja J, Nissen N, Naziri J, Yang W, Li Q, Tuli R. Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma. PLoS One. 2016 Mar 25;11(3):e0152172.
    • Singhi AD, Ali SM, Lacy J, Hendifar A, Nguyen K, Koo J, Chung JH, Greenbowe J, Ross JS, Nikiforova MN, et al. Identification of targetable ALK rearrangements in pancreatic ductal adenocarcinoma. J Natl Compr Canc Netw. 2017 May;15(5):555-562. PubMed PMID: 28476735.
    • Strosberg J, Wolin E, Chasen B, Kulke M, Bushnell D, Caplin M, Baum RP, Kunz P, Hobday T, Hendifar A, Oberg K, Sierra ML, Thevenet T, Margalet I, Ruszniewski P, Krenning E; NETTER-1 Study Group. Health-related quality of life in patients with progressive midgut neuroendocrine tumors treated with (177)Lu-Dotatate in the phase III NETTER-1 trial. J Clin Oncol. 2018 Jun 7:JCO2018785865. doi: 10.1200/JCO.2018.78.5865. [Epub ahead of print] PubMed PMID: 29878866.
    more

    Achievements

    Board Certifications

    • Board Certified in Hematology
    • Board Certified in Medical Oncology

    Awards & Activities

    • Super Doctors - 2013-present
    • Course Director, LACNETS & CFCF Annual Neuroendocrine Tumor Patient & Caregiver Educational Conference - 2015-present
    • Supportive Care Medicine Chair, Precision Promise Consortium, Pancreatic Cancer Action Network - 2016-present
    • Course Director, Gastrointestinal Cancer Conference - 2018
    more

    Patient Ratings & Comments Learn more

    Ratings

    Average Rating:
    4.9 / 5
    331 Ratings

    Rating Breakdown

    five star (306):
    four star (23):
    three star (2):
    two star (0):
    one star (0):

    Comments

    By Cedars-Sinai Patienton Sep 15, 2021

    Again......There is no better care than that given at the .cedars Cancer Center.

    By Cedars-Sinai Patienton Sep 09, 2021

    Extremely professional, caring, understanding and personable.I felt comfortable and had complete confidence with my doctor.

    By Cedars-Sinai Patienton Sep 09, 2021

    A very nice gentleman

    more